Figure 2
Figure 2. Evaluation of ex vivo modulation temperature with cryopreserved human UCB CD34+ cells with dmPGE2. (A) Genome-wide expression analysis on Affymetrix U133 plus 2.0 GeneChips of human UCB CD34+ cells treated with 10 µM of dmPGE2 for 2 hours at 4°C, 25°C, and 37°C. RMA log2 normalized expression levels for cells treated with dmPGE2 (y-axis) in comparison with vehicle-treated cells (x-axis). There were 2, 19, and 192 probe sets (red) with expression levels changing greater (or less) than fourfold due to dmPGE2 treatment at 4°C (left), 25°C (center), and 37°C (right), respectively. (B) GO enrichment analysis showing biological processes enriched in the upregulated probes induced by treatment with dmPGE2 at 37°C. Genes upregulated by dmPGE2 treatment at 37°C in CD34+ are listed for each GO category.

Evaluation of ex vivo modulation temperature with cryopreserved human UCB CD34+ cells with dmPGE2. (A) Genome-wide expression analysis on Affymetrix U133 plus 2.0 GeneChips of human UCB CD34+ cells treated with 10 µM of dmPGE2 for 2 hours at 4°C, 25°C, and 37°C. RMA log2 normalized expression levels for cells treated with dmPGE2 (y-axis) in comparison with vehicle-treated cells (x-axis). There were 2, 19, and 192 probe sets (red) with expression levels changing greater (or less) than fourfold due to dmPGE2 treatment at 4°C (left), 25°C (center), and 37°C (right), respectively. (B) GO enrichment analysis showing biological processes enriched in the upregulated probes induced by treatment with dmPGE2 at 37°C. Genes upregulated by dmPGE2 treatment at 37°C in CD34+ are listed for each GO category.

Close Modal

or Create an Account

Close Modal
Close Modal